T1	SNP 22 38	genetic variants
T2	Cancer 44 56	breast cance
T3	Association 0 11	Association
E1	Association:T3 snp_int:T1 bc:T2
T4	Entity 108 126	Chinese population
R1	Population_assignment Arg1:T1 Arg2:T4	
T5	Spec 516 523	explore
T6	Association 528 532	role
E2	Association:T6 bc:T7 snp_int:T8
R2	Speculation_marker Arg1:E2 Arg2:T5	
T7	Cancer 536 549	breast cancer
T8	SNP 536 573;639 641	breast cancer susceptibility variants 22
T9	Entity 579 625	Chinese population of Southern Chinese descent
R3	Population_assignment Arg1:T8 Arg2:T9	
T10	Entity 687 693	female
R4	Population_assignment Arg1:T8 Arg2:T10	
T11	Other_effect 738 757	clinicopathological
E3	Other_effect:T11 Agent:T13
T12	Spec 777 789	investigated
R5	Speculation_marker Arg1:E3 Arg2:T12	
T13	SNP 729 733	SNPs
R6	Equiv Arg1:T13 Arg2:T8	
T14	SNP 886 896	Eight SNPs
T15	Association 902 912	associated
E4	Association:T15 snp_int:T14 bc:T17
T16	Effect_Type 921 929	elevated
A1	Effect_Type E4 Increase
R7	Effect_type_marker Arg1:E4 Arg2:T16	
T17	Cancer 930 943	breast cancer
T18	SNP 950 959	Rs2046210
T19	Entity 960 966	6q25.1
R8	SNP_location Arg1:T18 Arg2:T19	
T20	Effect_Type 967 976	increased
T21	Association 991 995	risk
E5	Association:T21 bc:T22 snp_int:T18
A2	Effect_Type E5 Increase
R9	Effect_type_marker Arg1:E5 Arg2:T20	
T22	Cancer 977 990	breast cancer
T23	Entity 1003 1017	additive model
R10	Genotype Arg1:T18 Arg2:T23	
T24	Cancer 1122 1139;1145 1153	estrogen receptor positive
T25	Entity 1141 1143	ER
T26	Entity 1122 1139	estrogen receptor
R11	Equiv Arg1:T25 Arg2:T26	
T27	Cancer 1202 1213	ER-negative
T28	Neg 1205 1213	negative
T29	Entity 1202 1204	ER
T30	Organic_inorganic_molecules_affected 1106 1116	associated
E6	Organic_inorganic_molecules_affected:T30 Agent:T18 Theme:T26
E7	Organic_inorganic_molecules_affected:T30 Agent:T18 Theme:T29
R14	Negation_marker Arg1:E7 Arg2:T28	
T31	Effect_Type 1145 1153	positive
A3	Effect_Type E6 Increase
R15	Effect_type_marker Arg1:E6 Arg2:T31	
T32	SNP 1267 1276	Rs2046210
T33	Association 1286 1296	associated
E8	Association:T33 snp_int:T32 bc:T34 bc2:T35 bc3:T36
T34	Cancer 1302 1309;1332 1339	stage 1 disease
A4	Cancer_Type T34 Other
T35	Cancer 1311 1318;1332 1339	stage 2 disease
A5	Cancer_Type T35 Other
T36	Cancer 1324 1331;1332 1339	stage 3 disease
A6	Cancer_Type T36 Other
T37	Effect_Type 1492 1501	increased
T38	Cancer 1502 1515	breast cancer
T40	SNP 1599 1608	rs1219648
T41	SNP 1630 1639	rs2981582
T42	SNP 1661 1670	rs2981579
T43	SNP 1696 1706	rs11200014
T44	Entity 1456 1464	10q26.13
T45	Entity 1465 1470	FGFR2
T46	Association 1476 1486	associated
E9	Association:T46 bc:T38 snp_int:T40 snp_int2:T41 snp_int3:T42 snp_int4:T43
A7	Effect_Type E9 Increase
R21	Effect_type_marker Arg1:E9 Arg2:T37	
T47	SNP 1720 1729	rs7696175
T48	Entity 1730 1734	TLR1
T49	Entity 1736 1740	TLR6
T50	SNP 1742 1752	rs13281615
T51	Entity 1753 1757	8q24
T52	SNP 1763 1773	rs16886165
T53	Entity 1774 1780	MAP3K1
R25	SNP_location Arg1:T47 Arg2:T48	
R26	SNP_location Arg1:T50 Arg2:T51	
R27	SNP_coupled_gene Arg1:T52 Arg2:T53	
T54	Association 1791 1801	associated
E10	Association:T54 bc:T56 snp_int:T52 snp_int2:T50 snp_int3:T47
T55	Effect_Type 1807 1816	increased
T56	Cancer 1817 1830	breast cancer
A8	Effect_Type E10 Increase
R28	Effect_type_marker Arg1:E10 Arg2:T55	
T57	Cancer 2007 2025	ER-positive tumors
R29	SNP_location Arg1:T47 Arg2:T49	
T58	Association 1952 1962	associated
E11	Association:T58 bc:T59 snp_int:T61 snp_int2:T62 snp_int3:T63 snp_int4:T64 snp_int5:T65
T59	Cancer 1968 1981	breast cancer
T60	Level 1987 2000	predominantly
E12	Association:T58 bc:T57 snp_int:T61 snp_int2:T62 snp_int3:T63 snp_int4:T64 snp_int5:T65
A9	Level E12 High
R30	Level_marker Arg1:E12 Arg2:T60	
A10	Cancer_Type T57 ER+
T61	SNP 2027 2036	rs2981582
T62	SNP 2044 2053	rs4415084
T63	SNP 2062 2071	rs1219648
T64	SNP 2079 2088	rs2981579
T65	SNP 2100 2110	rs11200014
T66	Entity 2037 2042	FGFR2
T67	Entity 2054 2060	MRPS30
T68	Entity 2072 2077	FGFR2
T69	Entity 2089 2094	FGFR2
T70	Entity 2111 2116	FGFR2
R31	SNP_coupled_gene Arg1:T61 Arg2:T66	
R32	SNP_coupled_gene Arg1:T62 Arg2:T67	
R33	SNP_coupled_gene Arg1:T63 Arg2:T68	
R34	SNP_coupled_gene Arg1:T64 Arg2:T69	
R35	SNP_coupled_gene Arg1:T65 Arg2:T70	
T71	Interaction 2221 2258	combination of 6 or more risk alleles
T72	SNP 2236 2258	6 or more risk alleles
T73	SNP 2286 2301	≤3 risk alleles
E14	Interaction:T71 Entity:T72
T74	Effect_Type 2186 2203	increased by 90 %
A11	Effect_Type E14 Increase
T75	Entity 2129 2147	Chinese population
R36	Population_assignment Arg1:T72 Arg2:T75	
T76	Association 2161 2171	developing
E13	Association:T76 bc:T77 snp_int:E14
T77	Cancer 2172 2185	breast cancer
A12	Effect_Type E13 Increase
R37	Effect_type_marker Arg1:E13 Arg2:T74	
T78	SNP 1708 1716	Variants
T79	SNP 1942 1951	Five SNPs
T80	SNP 1436 1445	Four SNPs
R38	Member Arg1:T72 Arg2:T79	
R39	Equiv Arg1:T72 Arg2:T78	
R40	Member Arg1:T79 Arg2:T61	
R41	Member Arg1:T79 Arg2:T62	
R42	Member Arg1:T79 Arg2:T63	
R43	Member Arg1:T79 Arg2:T64	
R44	Member Arg1:T79 Arg2:T65	
R45	Equiv Arg1:T78 Arg2:T47	
R46	Equiv Arg1:T78 Arg2:T50	
R47	Equiv Arg1:T78 Arg2:T52	
R48	Population_assignment Arg1:T14 Arg2:T9	
E15	Association:T76 bc:T77 snp_int:T73
R49	Population_assignment Arg1:T73 Arg2:T75	
T81	Interaction 2272 2301	patients with ≤3 risk alleles
E16	Interaction:T81 Entity:T73
R50	Member Arg1:T14 Arg2:T18	
R52	Member Arg1:T80 Arg2:T40	
R53	Member Arg1:T80 Arg2:T41	
R54	Member Arg1:T80 Arg2:T42	
R55	Member Arg1:T80 Arg2:T43	
R57	Member Arg1:E14 Arg2:T32	
R56	Member Arg1:T72 Arg2:T80	
R58	Member Arg1:T14 Arg2:T80	
R60	Member Arg1:T14 Arg2:T79	
A13	SNP_Class T1 Common_variant
R61	Equiv Arg1:T9 Arg2:T4	
A14	Cancer_Type T24 ER+
A15	Cancer_Type T27 ER-
T82	Association 1106 1116	associated
E17	Association:T82 bc:T24 bc2:T27 snp_int:T18
R12	SNP_location Arg1:T80 Arg2:T44	
R13	SNP_coupled_gene Arg1:T80 Arg2:T45	
R16	Equiv Arg1:T75 Arg2:T9	
